Barclays’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-1
Closed 4674
2024
Q4
$0 Sell
1
-7,100
-100% ﹤0.01% 4568
2024
Q3
$4K Sell
7,101
-31,687
-82% -$17.8K ﹤0.01% 4214
2024
Q2
$24K Sell
38,788
-61,529
-61% -$38.1K ﹤0.01% 3874
2024
Q1
$258K Sell
100,317
-41,470
-29% -$107K ﹤0.01% 3208
2023
Q4
$289K Buy
141,787
+105,042
+286% +$214K ﹤0.01% 3337
2023
Q3
$62K Sell
36,745
-1,917
-5% -$3.24K ﹤0.01% 3509
2023
Q2
$75K Sell
38,662
-34,013
-47% -$66K ﹤0.01% 3513
2023
Q1
$202K Buy
72,675
+47,280
+186% +$131K ﹤0.01% 3144
2022
Q4
$88K Buy
25,395
+170
+0.7% +$589 ﹤0.01% 3538
2022
Q3
$64K Buy
25,225
+2,878
+13% +$7.3K ﹤0.01% 3580
2022
Q2
$54K Sell
22,347
-7,328
-25% -$17.7K ﹤0.01% 3706
2022
Q1
$123K Sell
29,675
-44,533
-60% -$185K ﹤0.01% 3581
2021
Q4
$954K Buy
74,208
+37,803
+104% +$486K ﹤0.01% 2232
2021
Q3
$393K Buy
36,405
+12,539
+53% +$135K ﹤0.01% 2703
2021
Q2
$218K Sell
23,866
-49,772
-68% -$455K ﹤0.01% 2854
2021
Q1
$694K Buy
73,638
+63,875
+654% +$602K ﹤0.01% 2492
2020
Q4
$38K Sell
9,763
-4,068
-29% -$15.8K ﹤0.01% 3272
2020
Q3
$37K Sell
13,831
-2,553
-16% -$6.83K ﹤0.01% 3381
2020
Q2
$109K Buy
16,384
+8,121
+98% +$54K ﹤0.01% 3079
2020
Q1
$48K Sell
8,263
-16,963
-67% -$98.5K ﹤0.01% 3118
2019
Q4
$225K Buy
25,226
+12,160
+93% +$108K ﹤0.01% 3121
2019
Q3
$112K Sell
13,066
-3,193
-20% -$27.4K ﹤0.01% 3344
2019
Q2
$181K Sell
16,259
-3,741
-19% -$41.6K ﹤0.01% 3261
2019
Q1
$266K Buy
20,000
+15,646
+359% +$208K ﹤0.01% 2902
2018
Q4
$67K Sell
4,354
-5,646
-56% -$86.9K ﹤0.01% 3096
2018
Q3
$142K Buy
+10,000
New +$142K ﹤0.01% 3237